PPV was higher for US than for MRI in HR+/HER2+ (0.67 vs 0.52) and HR−/HER2+ BC (0.55 vs 0.41); both methods had a similar PPV overall and in HR−/HER2− tumors. The gene discussed is ERBB2; the disease is breast cancer.